SIGLEC1 and colorectal carcinoma: In the current study, we characterized the frequency of different subsets of CD14+CD169+ cells in circulating monocytes and in TIMs by flow cytometry and detected the levels of plasma IL-10 and IL-12 as well as carcinoembryonic antigen (CEA) in CRC patients.